We used MCF-7 (luminal A) and BT-474 (HER2-enriched) cell lines for labeling with ERα, PR and HER2 antibody-fluorophore conjugates to ensure that flow cytometry is relevant to distinguish the molecular subtype of breast cancer. Here, ERBB2 is linked to breast carcinoma.